Cannabix Marijuana Breath Test Clears Key Regulatory Milestone: Handheld Breath Collection Unit (BCU) Passes FCC Electronic Emissions Testing

Core Viewpoint - Cannabix Technologies Inc. has successfully passed electronic emissions testing required by the FCC for its Cannabix Breath Collection Unit (BCU), marking a significant milestone towards commercialization of its Marijuana Breath Test (MBT) system [1][6]. Group 1: Testing and Compliance - The electronic emissions testing for the Cannabix BCU was conducted in accordance with CFR Title 47 FCC Part 15 for the U.S. market and ICES-003 Issue 7 for the Canadian market, ensuring compliance with RF emissions standards [3][6]. - Cannabix has received an ISO/IEC 17025 accredited test report confirming compliance with electronic emissions standards, which is essential for marketing the device in the U.S. [2][6]. Group 2: Product Development and Partnerships - The MBT system integrates Cannabix's proprietary Breath Collection Unit and Breath Cartridge technologies, designed for stable breath sample collection and analysis using liquid chromatography-mass spectrometry (LC-MS) methods [5][10]. - Cannabix has formed a strategic partnership with Omega Laboratories Inc., a leader in forensic drug testing, to advance the commercialization of the MBT system in the U.S. and Canada [5][10]. Group 3: Future Steps and Market Readiness - The successful completion of emissions testing is a key step towards the anticipated commercialization of the BCU, with engineering work focused on meeting compliance requirements [6][10]. - The BCU is designed to test for recent marijuana use, positioning Cannabix to address the growing demand for reliable drug testing technologies in various sectors [10].